• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Suanfarma, at the Core of a Better Life.

    Cognition Therapeutics Completes CT1812 Enrollment in DLB Trial

    GLOBENEWSWIRE

    Cognition Therapeutics Unveils Zervimesine Phase 3 Plan in AD

    GLOBENEWSWIRE

    Cognition Completes Enrollment in Phase 2 Study of Zervimesine

    GLOBENEWSWIRE

    Cognition Therapeutics Wraps up FDA Meeting for Zervimesine

    GLOBENEWSWIRE

    Cognition Therapeutics` CT1812 Study Results Accepted For AAIC Presentation

    GLOBENEWSWIRE

    Cognition Completes Enrollment in SHIMMER Phase 2 for DLB

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.